Qube Research & Technologies »

Aim Immunotech shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $1 2 0.50
2023-09-30 $1 2 0.50
2021-09-30 $32k 16k 2.02

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Amazon Call Option (AMZN)
Visa Com Cl A (V)
Wal-Mart Stores (WMT)
Johnson & Johnson Call Option (JNJ)
Oracle Corporation (ORCL)
Tesla Motors Call Option (TSLA)
Hess (HES)
McDonald's Corporation Put Option (MCD)
Amgen Call Option (AMGN)
S&p Global Call Option (SPGI)

View all positions for Qube Research & Technologies

Top funds holding Aim Immunotech

Vanguard Group
BlackRock
Geode Capital Management
Renaissance Technologies
State Street Corporation
Verition Fund Management
Bridgeway Capital Management
Morgan Stanley
Northern Trust
SeaCrest Wealth Management
DRW Holdings
Two Sigma Securities
ForthRight Wealth Management
Captrust Financial Advisors
Tower Research Capital

View all funds holding Aim Immunotech